We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
+8.78%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+535.77%
AUM
$3.13B
AUM Growth
+$281M
Cap. Flow
+$61.6M
Cap. Flow %
1.97%
Top 10 Hldgs %
12.2%
Holding
1,543
New
228
Increased
546
Reduced
510
Closed
166

Sector Composition

Rank Sector Weight
1 Energy 12.37%
2 Healthcare 10.59%
3 Industrials 9.5%
4 Financials 9.49%
5 Technology 9.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DAL icon
426
Delta Air Lines
DAL
$60.1B
$1.52M 0.05%
55,371
+1,660
+3% +$44.6K
MLM icon
427
Martin Marietta Materials
MLM
$33B
$1.5M 0.05%
14,996
+20
+0.1% +$1.97K
X
428
DELISTED
US Steel
X
$1.5M 0.05%
50,732
-22,982
-31% -$592K
KERX
429
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$1.5M 0.05%
115,467
-4,211
-4% -$50.3K
ECL icon
430
Ecolab
ECL
$79.9B
$1.49M 0.05%
14,305
-14
-0.1% -$1.46K
IJR icon
431
iShares Core S&P Small-Cap ETF
IJR
$112B
$1.49M 0.05%
27,324
+516
+2% +$27K
SDY icon
432
State Street SPDR S&P Dividend ETF
SDY
$22.1B
$1.48M 0.05%
20,429
+2,680
+15% +$193K
PDI icon
433
PIMCO Dynamic Income Fund
PDI
$7.42B
$1.48M 0.05%
50,622
+3,380
+7% +$98.9K
AWAY
434
DELISTED
HOMEAWAY INC COM
AWAY
$1.47M 0.05%
+35,945
New +$1.23M
OMC icon
435
Omnicom Group
OMC
$23.4B
$1.47M 0.05%
19,701
+67
+0.3% +$4.61K
XHB icon
436
State Street SPDR S&P Homebuilders ETF
XHB
$1.62B
$1.46M 0.05%
43,976
+24,991
+132% +$774K
TOL icon
437
Toll Brothers
TOL
$14.5B
$1.46M 0.05%
39,419
+10,658
+37% +$353K
HES
438
DELISTED
Hess
HES
$1.46M 0.05%
17,555
-1,322
-7% -$107K
FEX icon
439
First Trust Large Cap Core AlphaDEX Fund
FEX
$1.61B
$1.45M 0.05%
35,250
+9,629
+38% +$380K
FXO icon
440
First Trust Financials AlphaDEX Fund
FXO
$1.14B
$1.45M 0.05%
66,689
-1,760
-3% -$36.7K
VB icon
441
Vanguard Morningstar Small-Cap ETF
VB
$82.7B
$1.44M 0.05%
13,111
+347
+3% +$36.9K
AMAT icon
442
Applied Materials
AMAT
$428B
$1.43M 0.05%
81,056
+24,542
+43% +$428K
SRCL
443
DELISTED
Stericycle Inc
SRCL
$1.43M 0.05%
12,305
+628
+5% +$73.2K
WST icon
444
West Pharmaceutical
WST
$24.9B
$1.43M 0.05%
29,072
-928
-3% -$43.4K
NBL
445
DELISTED
Noble Energy, Inc.
NBL
$1.42M 0.05%
20,907
+7,291
+54% +$516K
SI
446
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
$1.42M 0.05%
10,260
-155
-1% -$20K
QCOR
447
DELISTED
QUESTCOR PHARMA INC
QCOR
$1.41M 0.05%
25,894
+15,044
+139% +$889K
IVZ icon
448
Invesco
IVZ
$13.9B
$1.41M 0.05%
38,644
+324
+0.8% +$11K
OVTI
449
DELISTED
OMNIVISION TECHNOLOGIES INC
OVTI
$1.4M 0.04%
81,550
+53,300
+189% +$808K
FYX icon
450
First Trust Small Cap Core AlphaDEX Fund
FYX
$1.41B
$1.4M 0.04%
28,814
+15,870
+123% +$732K

Similar funds

Oppenheimer & Co's Q4 2013 Portfolio in Review

As of Q4 2013, Oppenheimer & Co held 1,543 positions worth $3.13B, up 9.9% from $2.84B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Oppenheimer & Co's Q4 2013 filing shows 228 new, 546 increased, 510 reduced and 166 closed positions. Its largest new stake was TetraLogic Pharmaceuticals Corporation: 1,072,115 shares worth $10.2M. The largest sale was WisdomTree Emerging Markets Local Debt Fund, an estimated $5.52M.

By sector, the portfolio is most concentrated in Energy at 12% of assets, down from 13% a quarter earlier, followed by Healthcare and Industrials.

  • Oppenheimer & Co's largest Q4 2013 buy was TetraLogic Pharmaceuticals Corporation: 1,072,115 shares worth $10.2M.
  • Oppenheimer & Co added most to Invesco FTSE RAFI US 1000 ETF in Q4 2013, an estimated $8.14M increase.
  • Oppenheimer & Co's biggest Q4 2013 reduction was WisdomTree Emerging Markets Local Debt Fund, cutting an estimated $5.52M.
  • Oppenheimer & Co fully exited iShares Global Financials ETF in Q4 2013, selling an estimated $5.36M.
  • Oppenheimer & Co's ten largest holdings make up 12% of its $3.13B portfolio in Q4 2013.
  • Oppenheimer & Co opened 228 new positions and closed 166 in Q4 2013.
  • Oppenheimer & Co's portfolio value rose 9.9% quarter-over-quarter to $3.13B.

Based on Oppenheimer & Co's 13F filing for Q4 2013, filed 12 Feb 2014.